Literature DB >> 23377858

Neuroendocrine markers and psychological features in patients with irritable bowel syndrome.

Cristina Stasi1, Massimo Bellini, Francesco Costa, Maria Gloria Mumolo, Angelo Ricchiuti, Mariano Grosso, Emiliano Duranti, Maria Rosaria Metelli, Dario Gambaccini, Lea Bianchi, Gian Luca Di Tanna, Giacomo Laffi, Stefano Taddei, Santino Marchi.   

Abstract

BACKGROUND AND AIMS: The key role of the brain-gut axis in the pathophysiology of irritable bowel syndrome (IBS) has been recognized. The aim of this study was to assess the possible association between IBS, neuroendocrine markers, and psychological features.
METHODS: One hundred and twenty-five consecutive IBS patients and 105 healthy subjects were enrolled. Plasma serotonin, plasma and urinary cortisol, and plasma neuropeptide Y levels were evaluated. All patients were given a questionnaire to assess IBS symptom severity. In 66 patients, a psychodiagnostic assessment was carried out.
RESULTS: A high incidence of specific psychological features, including state anxiety (69.69 %), trait anxiety (54.54 %), obsessions and compulsions (28.78 %), was observed in IBS patients. A positive correlation between neuropeptide Y and state anxiety (r = 0.287, p = 0.024) and simulation/social ingenuity (r = 0.269, p = 0.039) was found in these patients. In diarrhea-predominant IBS, plasma cortisol was linearly related to plasma serotonin (r = 0.5663, p < 0.001).
CONCLUSIONS: In IBS patients, a significant correlation was found between specific psychological features and neuroendocrine markers, especially plasma cortisol and neuropeptide Y; in diarrhea-predominant IBS, a correlation between plasma cortisol and serotonin was found, although it needs to be confirmed in more extensive cohorts.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23377858     DOI: 10.1007/s00384-013-1646-4

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  34 in total

Review 1.  Psychosocial aspects of the functional gastrointestinal disorders.

Authors:  D A Drossman; F H Creed; K W Olden; J Svedlund; B B Toner; W E Whitehead
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

2.  The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress.

Authors:  C Y Francis; J Morris; P J Whorwell
Journal:  Aliment Pharmacol Ther       Date:  1997-04       Impact factor: 8.171

3.  Basal and stimulated hypothalamic-pituitary-adrenal axis activity in patients with functional gastrointestinal disorders and healthy controls.

Authors:  Andreas H Böhmelt; Urs M Nater; Saskia Franke; Dirk H Hellhammer; Ulrike Ehlert
Journal:  Psychosom Med       Date:  2005 Mar-Apr       Impact factor: 4.312

4.  An exaggerated sensory component of the gastrocolonic response in patients with irritable bowel syndrome.

Authors:  M Simrén; H Abrahamsson; E S Björnsson
Journal:  Gut       Date:  2001-01       Impact factor: 23.059

Review 5.  Altered neuro-endocrine-immune pathways in the irritable bowel syndrome: the top-down and the bottom-up model.

Authors:  Cristina Stasi; Massimo Rosselli; Massimo Bellini; Giacomo Laffi; Stefano Milani
Journal:  J Gastroenterol       Date:  2012-07-06       Impact factor: 7.527

6.  Regional cerebral activity in normal and pathological perception of visceral pain.

Authors:  D H Silverman; J A Munakata; H Ennes; M A Mandelkern; C K Hoh; E A Mayer
Journal:  Gastroenterology       Date:  1997-01       Impact factor: 22.682

7.  Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: a pilot study.

Authors:  C P Bearcroft; D Perrett; M J Farthing
Journal:  Gut       Date:  1998-01       Impact factor: 23.059

8.  Prevalence of psychiatric disorders in patients with irritable bowel syndrome.

Authors:  R B Lydiard; M D Fossey; W Marsh; J C Ballenger
Journal:  Psychosomatics       Date:  1993 May-Jun       Impact factor: 2.386

Review 9.  Management of irritable bowel syndrome.

Authors:  M C Gunn; A A Cavin; J C Mansfield
Journal:  Postgrad Med J       Date:  2003-03       Impact factor: 2.401

10.  Autonomic nervous system function in patients with functional abdominal pain. An experimental study.

Authors:  L S Jørgensen; P Christiansen; U Raundahl; S Ostgaard; N J Christensen; M Fenger; H Flachs
Journal:  Scand J Gastroenterol       Date:  1993-01       Impact factor: 2.423

View more
  11 in total

Review 1.  Serotonin receptors and their role in the pathophysiology and therapy of irritable bowel syndrome.

Authors:  C Stasi; M Bellini; G Bassotti; C Blandizzi; S Milani
Journal:  Tech Coloproctol       Date:  2014-01-15       Impact factor: 3.781

Review 2.  Advances in the management of constipation-predominant irritable bowel syndrome: the role of linaclotide.

Authors:  Siegfried W B Yu; Satish S C Rao
Journal:  Therap Adv Gastroenterol       Date:  2014-09       Impact factor: 4.409

Review 3.  Irritable bowel syndrome: a disease still searching for pathogenesis, diagnosis and therapy.

Authors:  Massimo Bellini; Dario Gambaccini; Cristina Stasi; Maria Teresa Urbano; Santino Marchi; Paolo Usai-Satta
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

Review 4.  Irritable bowel syndrome and chronic constipation: Fact and fiction.

Authors:  Massimo Bellini; Dario Gambaccini; Paolo Usai-Satta; Nicola De Bortoli; Lorenzo Bertani; Santino Marchi; Cristina Stasi
Journal:  World J Gastroenterol       Date:  2015-10-28       Impact factor: 5.742

5.  Irritable bowel syndrome is associated not only with organic but also psychogenic erectile dysfunction.

Authors:  C-Y Hsu; C-L Lin; C-H Kao
Journal:  Int J Impot Res       Date:  2015-10-08       Impact factor: 2.896

Review 6.  The Role of H. pylori CagA in Regulating Hormones of Functional Dyspepsia Patients.

Authors:  Wang-Ping Meng; Zhong-Qiong Wang; Jia-Qi Deng; Yi Liu; Ming-Ming Deng; Mu-Han Lü
Journal:  Gastroenterol Res Pract       Date:  2016-10-20       Impact factor: 2.260

7.  Neuroendocrine Dysregulation in Irritable Bowel Syndrome Patients: A Pilot Study.

Authors:  Cristina Stasi; Massimo Bellini; Dario Gambaccini; Emiliano Duranti; Nicola de Bortoli; Bernardo Fani; Eleonora Albano; Salvatore Russo; Isabella Sudano; Giacomo Laffi; Stefano Taddei; Santino Marchi; Rosa Maria Bruno
Journal:  J Neurogastroenterol Motil       Date:  2017-07-30       Impact factor: 4.924

Review 8.  Gut Biofactory-Neurocompetent Metabolites within the Gastrointestinal Tract. A Scoping Review.

Authors:  Karolina Skonieczna-Żydecka; Karolina Jakubczyk; Dominika Maciejewska-Markiewicz; Katarzyna Janda; Karolina Kaźmierczak-Siedlecka; Mariusz Kaczmarczyk; Igor Łoniewski; Wojciech Marlicz
Journal:  Nutrients       Date:  2020-11-01       Impact factor: 5.717

9.  Intrinsic brain abnormalities of irritable bowel syndrome with diarrhea: a preliminary resting-state functional magnetic resonance imaging study.

Authors:  Weiqun Ao; Yougen Cheng; Mingxian Chen; Fuquan Wei; Guangzhao Yang; Yongyu An; Fan Mao; Xiandi Zhu; Guoqun Mao
Journal:  BMC Med Imaging       Date:  2021-01-06       Impact factor: 1.930

10.  Subthreshold Psychiatric Psychopathology in Functional Gastrointestinal Disorders: Can It Be the Bridge between Gastroenterology and Psychiatry?

Authors:  Cristina Stasi; Cristiana Nisita; Sonia Cortopassi; Giorgio Corretti; Dario Gambaccini; Nicola De Bortoli; Bernardo Fani; Natalia Simonetti; Angelo Ricchiuti; Liliana Dell'Osso; Santino Marchi; Massimo Bellini
Journal:  Gastroenterol Res Pract       Date:  2017-10-30       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.